HopeStage
Back to all studies
CompletedNCT05892432

Oral semaglutide and alcohol use: randomized study

About this title

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Read the official source — NCT05892432
Medication studyAges 21+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 21 years.

Listed locations
AuroraSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 11, 2024
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
University of Colorado, Denver
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 21 Years
Official registry ID
NCT05892432
Official title
Show the full official title

Randomized, Controlled Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Aurora

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Colorado, Denver, a university.

Did this study involve medication?

Yes. The study involved medication, including Semaglutide 3 MG [Rybelsus], Semaglutide 7 MG [Rybelsus] and Placebo.

Who was this study for?

Listed age limits: from 21 years.

Want to explore more studies?

Explore studies